Download signNow app
4.7 / 5 rating on

Form 20 F Ascendis Pharma As For Dec 31 Streetinsider Com

Use a Form 20 F Ascendis Pharma AS For Dec 31 StreetInsider com template to make your document workflow more streamlined.

What this Form 20-F page represents

Form 20 F Ascendis Pharma As For Dec 31 Streetinsider Com appears to identify Ascendis Pharma’s Form 20-F annual report for the fiscal year ended December 31. Form 20-F is an SEC filing used by a foreign private issuer to report annual financial and business information to U.S. investors. It is not a tax form or an individual signature form. The filing generally combines audited financial statements, operating information, risk disclosures, and governance information. Confirm the exact SEC filing, accession number, reporting period, and signer requirements before preparing or executing any copy.

Who works with this Form 20-F

Finance and reporting

Public-company finance teams use the Form 20-F workflow to coordinate annual-report review, executive signatures, and controlled records before SEC submission.

Legal and investor relations

Legal and investor-relations teams review disclosures, maintain approval evidence, and coordinate signers without circulating uncontrolled PDF copies.

Teams that handle this filing

  • Ascendis Pharma’s finance and reporting leadership can use a controlled template to route the annual Form 20-F for executive review and signature. The audit trail preserves execution evidence while the team separately manages SEC filing accuracy, financial-statement approval, and submission requirements.
  • Legal and investor-relations reviewers can inspect the final reporting-period PDF, confirm the assigned approval sequence, and export the signed record. signNow’s role-based workflow helps separate preparation, review, and signature without treating the platform as the source of SEC filing authority.

How the Form 20-F workflow works

The workflow moves the identified Ascendis Pharma filing from an approved source PDF through field preparation, review, signature, and controlled retention.

  • Upload document: Upload the approved Ascendis Pharma Form 20-F PDF into signNow.
  • Prepare fields: Review detected fields and place signature, date, and approval fields.
  • Assign signers: Assign each field to the authorized reviewer or signer.
  • Complete and store: Complete signatures, preserve the audit trail, and export the final record.

Complete the Form 20-F workflow

Use this sequence for the identified annual-report approval record, then complete any separate SEC submission steps required by the issuer’s filing process.

  • Upload PDF:

     Upload the approved Form 20-F PDF.

  • Check fields:

     Review detected fields and add required fields.

  • Assign roles:

     Assign authorized reviewers and signers.

  • Send document:

     Send the prepared document through signNow.

  • Store evidence:

     Review the completed PDF and audit trail.
be ready to get more
Get legally-binding signatures now!
Start free trialRequest a call
  • Best ROI. Our customers achieve an average 7x ROI within the first six months.
  • Scales with your use cases. From SMBs to mid-market, airSlate SignNow delivers results for businesses of all sizes.
  • Intuitive UI and API. Sign and send documents from your apps in minutes.

How the audit trail records Form 20-F activity

A signNow audit trail links each signer action to the specific Form 20-F record, creating an evidence package for internal review.

01

Authenticate signer:

 Records the signer’s email, authentication event, and selected verification method.
02

Capture timestamp:

 Captures the date and time for every signing action.
03

Hash document:

 Associates the completed Form 20-F file with document-integrity data.
04

Seal record:

 Preserves the completed record and signing history against later alteration.
05

Log actions:

 Logs views, field changes, signatures, and completion status.
06

Export evidence:

 Exports the completed document and audit trail for controlled retention.

Recommended setup for Form 20-F

Configure the signing record around the approved filing PDF, authorized signers, audit evidence, and Ascendis Pharma’s records policy.

SettingRecommendation
Authentication methodEmail verification with two-factor authentication
Signature typeElectronic signature with recorded intent
Audit trailEnabled for every signer action
Document retentionIssuer-approved SEC records schedule
EncryptionTLS 1.2/1.3 and AES-256 protection

Features that support Form 20-F review

signNow features can organize execution evidence around the identified filing, while Ascendis Pharma remains responsible for SEC accuracy, authorization, and submission.

Controlled source

Upload the approved Ascendis Pharma Form 20-F PDF and preserve the original file before adding signature or approval fields.

Field review

Review detected fields and add only the fields required by the approved signing process, reducing manual placement errors.

Signer assignment

Assign executives, counsel, or designated reviewers to specific fields so responsibility is visible before signing begins.

Audit evidence

Capture timestamps, signer activity, and completion history in an audit trail linked to the executed record.

Reusable workflow

Use reusable templates for recurring annual-report approval steps while requiring a fresh review of each reporting period.

Record export

Export the signed filing and audit trail for storage with the issuer’s SEC and corporate records.

Security controls for signed records

Transport encryption:

 TLS 1.2/1.3 in transit

Storage encryption:

 AES-256 at rest

Control reporting:

 SOC 2 Type II certified

Security management:

 ISO 27001 certified

Electronic records:

 ESIGN and UETA compliant

Signer protection:

 Two-factor authentication available

Connect the filing workflow to business systems

Named signNow integrations can connect Form 20-F approval records with the systems used for reporting, document control, storage, and project coordination.

Salesforce
Procore
Zapier
Microsoft Teams
Hub spot
Box
Microsoft

Record-keeping practices for Form 20-F

Preserve the executed filing and evidence package under Ascendis Pharma’s records policy, while checking SEC requirements and the company’s applicable reporting controls.

Use an issuer-approved retention schedule

Keep the SEC-filed PDF, signed copy, audit trail, and supporting approval record together. The available authority does not provide a Form 20-F-specific retention period, so apply the issuer’s documented records policy and any applicable SEC, audit, and corporate-governance requirements rather than importing a tax or healthcare period.

Export the audit trail promptly

Export the completed Form 20-F and signNow audit trail after execution, then verify that the downloaded files open correctly and correspond to the intended reporting period. Record the export date, responsible owner, filing identifier, and storage location in the company’s controlled records index.

Separate drafts from the filed record

Restrict editing and deletion rights for the completed annual report. Preserve the source PDF separately from the executed copy, use access-controlled storage, and document any replacement or correction so reviewers can distinguish the filed version from later working drafts.

Verify filing identity before signing

Before signature, reconcile the reporting period, company name, financial-statement version, signer authority, and SEC submission package. signNow can document execution, but Ascendis Pharma and its advisers remain responsible for the filing’s accuracy and compliance with SEC requirements.

Challenges when preparing this filing

  • Using an outdated Ascendis Pharma annual-report PDF can create inconsistencies between the signed record and the SEC submission package.
  • Assigning signature fields before confirming executive authority can leave the filing’s approval chain incomplete or difficult to evidence.
  • Combining draft financial statements with the final Form 20-F can cause reviewers to sign the wrong reporting-period version.
  • Saving the signed PDF without its audit trail weakens the record showing who acted, when, and on which document.

Compare signing workflows for this filing

signNow supports the document-signing workflow described here; competitor capabilities are marked Not verified where the available source does not establish a fact.

FeaturesignNowDocuSignAdobe Acrobat Sign
Upload and field detectionYesNot verifiedNot verified
Signer audit trailYesNot verifiedNot verified
Secure document storageYesNot verifiedNot verified
Mobile signing supportYesNot verifiedNot verified

Form 20-F signing questions

These answers address document preparation, signer evidence, electronic-record rules, and retention for the identified Ascendis Pharma filing workflow.

Upload the approved source PDF again and confirm that the file opens before placing fields. If the document is an image-only scan, manually add the required fields and compare the completed PDF with the source before sending.

Open the assigned transaction and verify that every signature, date, and approval field has an assigned recipient. signNow templates can preserve field placement, but each annual reporting period still requires a document-specific review.

Use signNow’s audit trail and completion record to identify the signer, timestamps, and actions. If the signer’s identity requirements exceed email authentication, configure stronger verification before resending the transaction.

The Business plan includes legally binding eSignatures and audit trails. Business Premium adds bulk send, while Enterprise adds advanced signer authentication. Select the plan based on the filing process and required controls.

ESIGN and UETA can support electronic records when intent, consent, attribution, and reproducibility are established. They do not authorize an inaccurate SEC filing or replace the issuer’s separate submission obligations.

Export both the completed Form 20-F record and its audit trail, then store them under the issuer’s approved records policy. Confirm the reporting period, signer authority, and final SEC submission package before archival.

ROI at a Glance

Key performance indicators that demonstrate SignNow's proven track record.

28M+Documents signed
13+Years in business
4.6/5Average G2 rating

BE READY TO GET MORE

Get this form now!

If you believe that this page should be taken down, please follow our DMCA take-down process.